NCT03175731View on ClinicalTrials.gov

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Liver CirrhosisHypertension, Portal
Interventions
DRUG

Proton Pump Inhibitors

Pantoprazole 40mg per day intravenously or orally for 2 weeks after endoscopic treatment.

DRUG

Placebo

Placebo 40mg per day intravenously or orally for 2 weeks after endoscopic treatment.

Trial Locations (1)

250012

Department of Gastroenterology,Qilu Hospital,Shandong University, Jinan

All Listed Sponsors
lead

Yanjing Gao

OTHER

NCT03175731 - PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) | Biotech Hunter | Biotech Hunter